Media Contacts

Matt Miller
Director, Communications and Public Relations
mrmille2@uci.edu

Michelle Strombeck
Manager, Communications and Public Relations
312-498-8208
mstrombe@hs.uci.edu

Stay Connected

Mark Fisher, MD - study chronic kidney disease and stroke

Nov 20, 2023 | UCI News

UC Irvine-led study is first to find brain hemorrhage cause other than injured blood vessels

Discovery deepens understanding of cerebral microbleeds and may offer new therapeutic targets.
Diego Pizzagalli

Nov 16, 2023 | UCI News

Diego A. Pizzagalli named founding director of UC Irvine depression research institute

Harvard researcher joins UCI to build world-class, transdisciplinary program and will hold faculty appointment in the Department of Psychiatry & Human Behavior at the School of Medicine.

Lab-grown skeletal muscle cells

Nov 09, 2023 | UCI School of Medicine

UC Irvine researchers discover how to better support lab grown muscle cells after transplantation.

Researchers now have the recipe required to make muscle in the lab which can be used to treat a broad range of debilitating muscle disorders.
Aileen Andersen speaking at Sue & Bill Gross Stem Cell Center

Sep 28, 2023 | UCI News

UC Irvine named one of CIRM’s cell and gene therapy manufacturing facilities

UCI has earned a $2 million state grant that will allow the campus stem cell center to advance regenerative medicine.
Headshot of Federico Vaca

Sep 25, 2023 | UCI News

Dr. Federico Vaca to lead Association for the Advancement of Automotive Medicine

UCI physician-scholar Federico E. Vaca, MD, MPH, professor in the Department of Emergency Medicine, is lauded for research on traffic crash injuries and prevention.

Michael Demetriou, MD, PhD posing for the picture

Sep 14, 2023 | UCI School of Medicine

UCI researchers announce publication of an open-label clinical trial suggesting that N-acetylglucosamine restores neurological function in Multiple Sclerosis patients

Researchers say this dietary supplement reduced inflammation and neurodegeneration markers in patients already on FDA-approved immune therapy.

Carrie Chandwani, Lidia Flores and Sean Young

Sep 11, 2023 | UCI School of Medicine

UCI-led research found internet searches increased for self-managed abortions when Roe v. Wade was overturned

UCI researcher, Sean Young, PhD, professor in the Departments of Emergency Medicine and Informatics, and colleagues, have found that internet searches for how to give yourself an abortion, have increased since Roe v. Wade was overturned.

Crystal structure of two nanobodies binding to a rhodopsin dimer.

Aug 29, 2023 | UCI School of Medicine

UC Irvine researchers discover a nanobody which may lead to treatment for Retinitis Pigmentosa

A special antibody derived from llamas — called a nanobody — can stop the misfolding and the activation of Rhodopsin, a molecule whose mutations can lead to blindness.

A line graph of GLP-1 Receptor Agonist Publications. The x-axis is labeled year. The y-axis is Number of Publications in PubMED.

Aug 28, 2023 | UCI School of Medicine

Researchers at UC Irvine issue a warning that GLP-1RAs may be dangerous for children

The use of glucagon-like peptide-1 receptor agonists in popular weight loss drugs like Ozempic and Wegovy could threaten pediatric health.
Bar graph about Estimated 10-Year Cardiovascular Disease Risk and Projected Number of Cardiovascular Events (in Millions) Without and With Semaglutide Treatment.

Aug 15, 2023 | UCI School of Medicine

Recent study at UC Irvine found that semaglutide medication may benefit 93 million U.S. adults

The popular weight loss medication may prevent up to 1.5 million heart attacks and strokes over 10 years, and could result in 43 million fewer obese people.